The Short Bowel Syndrome Market was characterized by intense competition and significant research and development activities. Key pharmaceutical companies and biotech firms were striving to gain a competitive edge in this niche market segment. Some of the prominent players in the SBS market included Shire (a Takeda company), Zealand Pharma, OxThera, and Emmaus Life Sciences.
These companies...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian